This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Alphabet, Tesla, Sony, Tredegar and CVD Equipment
by Zacks Equity Research
Alphabet is riding strong AI-driven growth as Google Cloud backlog surges, generative AI revenues jump and Search and YouTube benefit from rising engagement.
Top Analyst Reports for Alphabet, Tesla & Sony
by Mark Vickery
Alphabet leads Zacks' top analyst reports, with Tesla and Sony also featured as new research highlights ahead of Wall Street.
TG's Q3 Earnings Surge Y/Y on Strong Aluminum Demand, Stock Up 33%
by Zacks Equity Research
Tredegar's Q3 earnings soar year over year on robust aluminum extrusion demand and cost controls, despite tariff challenges and mixed order trends.
The Zacks Analyst Blog Highlights NVIDIA, Roche, Lam Research, Tredegar and Kewaunee Scientific
by Zacks Equity Research
NVIDIA, Roche, and Lam Research lead this week's top Zacks research picks, while Tredegar and Kewaunee Scientific highlight strong niche and microcap opportunities.
Top Stock Reports for NVIDIA, Roche & Lam Research
by Mark Vickery
NVIDIA, Roche, and Lam Research lead today's top Zacks reports, showcasing standout growth drivers and sector-specific strengths.
Tredegar's Q2 Earnings Slide Y/Y on Cost, Volume Pressures
by Zacks Equity Research
Higher sales couldn't offset cost hikes and weaker film demand, leading to TG's Q2 year-over-year EPS drop despite aluminum volume gains.
Tredegar Q1 Earnings Down Y/Y as Aluminum Costs Weigh on Margins
by Zacks Equity Research
TG's Q1 earnings fall year over year despite a 14% sales rise, as rising aluminum costs and margin pressures impacted profitability, partly offset by strong PE Films gains.
The Zacks Analyst Blog Highlights NVIDIA, Abbott Laboratories, Linde and Tredegar
by Zacks Equity Research
NVIDIA, Abbott Laboratories, Linde and Tredegar are part of the Zacks top Analyst Blog
Top Stock Reports for NVIDIA, Abbott Laboratories & Linde
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Abbott Laboratories (ABT) and Linde plc (LIN), as well as a micro-cap stock Tredegar Corp. (TG).
Tredegar Stock Rises 8% on Narrower Y/Y Loss in Q4, PE Films Unit Aids
by Zacks Equity Research
TG incurs a net loss in Q4, narrowing year over year due to the strong PE Films and Aluminum Extrusions segment, but faces headwinds from supply chain challenges.